This inventor holds 2 USPTO granted patents. Top assignees: The United States of America as Represented by the Department of Health, The United States of America as Represented by the Secretary of. Active years: 1996-1998.
Company Filing History:
1 out of 1,217 
1 out of 2,202 
Years Active: 1996-1998
Title: Sven Harmsen: Innovator in Dimeric Naphthylisoquinoline Alkaloids
Introduction
Sven Harmsen is a notable inventor based in Wurzburg, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of dimeric naphthylisoquinoline alkaloids. With a total of 2 patents to his name, his work has implications for antiviral compounds and their synthesis methods.
Latest Patents
Harmsen's latest patents focus on the preparation of dimeric naphthylisoquinoline alkaloids. The methods he developed involve coupling two monomeric naphthylisoquinoline alkaloids, which can be identical or different. This innovative approach allows for the formation of both homodimers and heterodimers, including the antiviral michellamines. His inventions also encompass new, medically useful homodimeric and heterodimeric naphthylisoquinoline compounds and their derivatives.
Career Highlights
Throughout his career, Sven Harmsen has worked with prominent organizations, including the United States of America as represented by the Department of Health. His contributions to the field have been recognized for their potential impact on medical applications.
Collaborations
Harmsen has collaborated with esteemed colleagues such as Gerhard Bringmann and Michael R Boyd. These partnerships have furthered his research and development efforts in the field of medicinal chemistry.
Conclusion
Sven Harmsen's innovative work in the synthesis of dimeric naphthylisoquinoline alkaloids showcases his commitment to advancing medicinal chemistry. His patents reflect a significant contribution to the development of new antiviral compounds.